the patient was treated at the royal devon & exeter nhs foundation trust.
.
hello,
.
.
.
.
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.